Literature DB >> 6147381

Thy-1 antigen-bearing dendritic cells in murine epidermis are derived from bone marrow precursors.

P R Bergstresser, R E Tigelaar, J W Streilein.   

Abstract

Thy-1 antigen is expressed on a dendritic subpopulation of cells in murine epidermis. Numbering between 200 and 500/mm2 surface area in abdominal skin, they are distinct from the dendritic Langerhans cells (LCs) and melanocytes. Since immigrant lymphoid cells as well as constitutive cells in various organs have been demonstrated to be Thy-1+, their origin and function are not certain. To assess these issues, two experimental protocols were established. First, grafts of whole skin from AKR mice were placed orthotopically on (AKD2)F1 recipients. Immigration of recipient-derived cells into graft epidermis was assessed histologically by fluorescence microscopy employing monoclonal anti-Thy-1.2 and anti-I-Ad antibodies. Second, bone marrow chimeras were established in AKR recipients after lethal irradiation and reconstitution with cells from (AKD2)F1 donors. In the first protocol, dendritic I-Ad+ LCs of donor origin infiltrated each graft to normal densities within 2 weeks. Thy-1.2+ cells also immigrated into the same grafts, but at much slower rates. In the second protocol, bone marrow-derived Thy-1.2+ cells populated normal skin epidermis slowly over several months, with densities reaching 70/mm2. We conclude that some, if not all, Thy-1+ cells in normal murine epidermis are derived from bone marrow precursors, that their infiltration rates differ substantially from those of LCs, and that those factors which govern immigration rates into adult skin derive from the skin itself rather than from the systemic availability of their precursors. We suggest that the function of Thy-1+ epidermal cells will therefore reside among those usually ascribed to recirculating hematogenous cells, including the possibility that they may down-regulate immunizing signals that emerge from skin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147381     DOI: 10.1111/1523-1747.ep12262587

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  Epidermal T lymphocytes--ontogeny, features and function.

Authors:  E Payer; A Elbe; G Stingl
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Induction of Thy-1 antigen on murine keratinocytes.

Authors:  A Scheynius; L Klareskog; R Holmdahl; P Larsson
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  Gamma delta antigen receptors of Thy-1+ dendritic epidermal cells: implications for thymic differentiation.

Authors:  J P Allison; W L Havran; D Asarnow; R E Tigelaar; P W Tucker; M Bonyhadi
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  Thy-1+ dendritic epidermal cells belong to the T-cell lineage.

Authors:  G Stingl; K C Gunter; E Tschachler; H Yamada; R I Lechler; W M Yokoyama; G Steiner; R N Germain; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  T cells developing in fetal thymus of T-cell receptor alpha-chain transgenic mice colonize gammadelta T-cell-specific epithelial niches but lack long-term reconstituting potential.

Authors:  Karin Leandersson; Elin Jaensson; Fredrik Ivars
Journal:  Immunology       Date:  2006-09       Impact factor: 7.397

6.  Absence of CD4 or CD8 lymphocytes changes infiltration of inflammatory cells and profiles of cytokine expression in skin wounds, but does not impair healing.

Authors:  Lin Chen; Nisha D Mehta; Yan Zhao; Luisa A DiPietro
Journal:  Exp Dermatol       Date:  2014-03       Impact factor: 3.960

7.  Limited diversity of T-cell receptor gamma-chain expression of murine Thy-1+ dendritic epidermal cells revealed by V gamma 3-specific monoclonal antibody.

Authors:  W L Havran; S Grell; G Duwe; J Kimura; A Wilson; A M Kruisbeek; R L O'Brien; W Born; R E Tigelaar; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.